Log In
BCIQ
Print this Print this
 

CyCol

  Manage Alerts
Collapse Summary General Information
Company Sigmoid Pharma Ltd.
DescriptionOral formulation of solubilized cyclosporine
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis
Regulatory Designation
PartnerPharmascience Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/29/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today